Cefepime for Injection USP and Dextrose Injection USP recall: Particulate Matter
Cefepime for Injection USP and Dextrose Injection USP, in Duplex Drug Delivery System, 1 g in 50 mL duplex container, For IV Use Only, Single Dose…
Why was Cefepime for Injection USP and Dextrose Injection USP recalled?
Presence of Particulate Matter: The 1g Cefepime for Injection USP and Dextrose Injection USP lot has been found to contain visible organic particulate matter in a reserve sample unit.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot H3A744, Exp 01/15
- Product
- Cefepime for Injection USP and Dextrose Injection USP, in Duplex Drug Delivery System, 1 g in 50 mL duplex container, For IV Use Only, Single Dose…
- Recalling firm
- B. Braun Medical Inc
- Quantity
- 18,936 Containers
- Distribution
- Nationwide
- Recall date
- February 12, 2014
- Classification
- Class I
- Status
- Terminated
- Agency
- FDA (drug)